for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ConvaTec Group PLC

CTEC.L

Latest Trade

177.70GBp

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

113.25

 - 

240.50

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
177.70
Open
--
Volume
--
3M AVG Volume
61.06
Today's High
--
Today's Low
--
52 Week High
240.50
52 Week Low
113.25
Shares Out (MIL)
1,977.35
Market Cap (MIL)
3,459.33
Forward P/E
17.10
Dividend (Yield %)
--

Next Event

Q3 2019 ConvaTec Group PLC Trading Statement Release

Latest Developments

More

Convatec Appoints John McAdam As Chairman

ConvaTec Group Maintains Its FY Guidance

Scapa Tapes Files Complaint Against ConvaTec, Claiming Damages Over $83.8 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About ConvaTec Group PLC

ConvaTec Group PLC is a United Kingdom-based medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets.

Industry

Medical Equipment & Supplies

Contact Info

Fl 7, 3 Forbury Place, 23 Forbury Road

https://www.convatecgroup.com/

Executive Leadership

Rick D. Anderson

Interim Chairman of the Board, Interim Chief Executive Officer

Frank Schulkes

Chief Financial Officer, Executive Director

Stephan Bonnelycke

Franchise President - Ostomy Care

Frank Gehres

Franchise President – Continence and Critical Care

Kjersti Grimsrud

President - EMEA

Key Stats

2.62 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

1.7K

2017

1.8K

2018

1.8K

2019(E)

1.8K
EPS (USD)

2016

0.130

2017

0.160

2018

0.160

2019(E)

0.127
Price To Earnings (TTM)
26.54
Price To Sales (TTM)
2.40
Price To Book (MRQ)
2.70
Price To Cash Flow (TTM)
11.97
Total Debt To Equity (MRQ)
99.41
LT Debt To Equity (MRQ)
94.42
Return on Investment (TTM)
4.80
Return on Equity (TTM)
4.29

Latest News

UPDATE 1-ConvaTec revenue falls on weak demand in Americas

Britain's ConvaTec Group Plc reported lower quarterly revenue on Friday as the medical products maker was hit by wilting demand in its biggest market, the Americas, while inventory troubles continued to plague the company back home.

ConvaTec logs softer 1st-qtr revenue on weak Americas business

ConvaTec Group Plc reported lower revenue for the first quarter on Friday, hit by wilting demand for some its older products and weaker income from the Americas, its biggest market.

Convatec shares jump on report of potential takeover interest

Shares in Convatec jumped to one-month highs on Tuesday after Swedish business daily Dagens Industri said several investors are considering an offer for the British medical device maker after the recent slump in its stock.

Medical device maker ConvaTec names Genus top boss as CEO

British medical devices maker ConvaTec Group Plc on Monday named Genus Plc's top boss Karim Bitar as its chief executive officer and said Chairman Christopher Gent would retire from his role.

Medical device maker ConvaTec names Karim Bitar CEO

British medical devices maker ConvaTec Group Plc on Monday named Genus Plc's top boss Karim Bitar as its chief executive officer and said Chairman Christopher Gent would retire from his role.

ConvaTec to appoint Karim Bitar from Genus as CEO - Sky News

Catheter and colostomy bag maker ConvaTec Group Plc will on Monday appoint Karim Bitar as the company's chief executive officer, and will announce the departure of its Chairman Christopher Gent, Sky News reported on Sunday.

UPDATE 2-FTSE 100 squeezes out gains; ConvaTec drags midcaps

* ConvaTec slumps on mid-caps (Adds company news items, updates to closing prices)

ConvaTec's shares plummet on weak results, draws up turnaround plan

Shares of ConvaTec plunged on Thursday after the medical devices maker reported "disappointing" annual results and launched a turnaround plan, which would include a $150 million (117 million pounds) investment over three years to boost sales and profit.

Medical device firm ConvaTec adjusts for Brexit disruptions

Catheter and colostomy bag maker ConvaTec played down the risks of even a no-deal Brexit to its business on Thursday, saying it was making plans to stock pile appropriately to deal with any potential supply disruptions.

FTSE shrugs off Brexit impasse while Convatec and Superdry sink

Britain's top share index managed a modest gain on Monday as a deadlock in Brexit talks depressed domestic stocks but helped multinational exporter companies as it weakened the pound.

ConvaTec shares plunge on profit warning and CEO departure

ConvaTec <CTEC.L> warned of lower sales and profitability and announced the departure of its CEO on Monday, sending shares in the British medical devices maker tumbling more than 30 percent.

ConvaTec slashes forecast on change in customer's inventory policy

British medical devices maker ConvaTec on Monday lowered its expectations for organic revenue and adjusted operating earnings margin for the full year, citing a change in inventory policy by its largest customer in its Infusion Devices business.

BRIEF-UBS Says Nordic Capital Sold 143.2 Mln Shares In Convatec

* NORDIC CAPITAL IT SOLD 143.2 MILLION ORDINARY SHARES IN CONVATEC GROUP PLC

ConvaTec first-quarter revenue up 13.7 percent

British medical devices maker ConvaTec <CTEC.L> on Wednesday posted a 13.7 rise in first-quarter revenue, as acquisitions and favourable foreign exchange movements helped offset the persisting impact of supply chain disruptions in its businesses.

BRIEF-Convatec Group Q1 Group Revenue $458.2 Mln, Up 3.7 Pct

* 2018 FINANCIAL GUIDANCE RE-AFFIRMED: ORGANIC REVENUE GROWTH 2.5% TO 3.0%; ADJUSTED EBIT MARGIN 24% TO 25%

Britain's ConvaTec Q1 revenue up 13.7 pct

British medical devices maker ConvaTec on Wednesday posted a 13.7 rise in first-quarter revenue, as acquisitions and favourable foreign exchange movements helped offset the persisting impact of supply chain disruptions in its businesses.

BRIEF-Convatec Says Acquired J&R Medical LLC

* CONVATEC HAS DIVESTED ITS RESPIRATORY DELIVERY BUSINESS IN ARIZONA AND UTAH

ConvaTec beats low full-year expectations, shares rise

British medical devices maker ConvaTec <CTEC.L> posted better than expected 2017 profit and revenue on Thursday after supply chain problems that it said have now been resolved, lifting its share price by nearly 7 percent.

Britain's ConvaTec 2017 profit down 3.3 percent on supply issues

British medical devices firm ConvaTec said 2017 profit fell 3.3 percent, bogged down by supply issues at its top two divisions and lower sales from new products.

BRIEF-Convatec Sees FY 2018 Organic Revenue Growth Of 2.5% - 3.0%

* FY GROUP REPORTED REVENUE OF $1,764.6 MILLION GREW 4.5% YEAR ON YEAR, 4.1% 3 CER OR 2.3% 4 ORGANICALLY VERSUS. REVISED GUIDANCE OF 1% TO 2% ORGANIC REVENUE GROWTH

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up